Unilever Acquires Grüns: Reshaping US Greens Supplement Market & Portfolio Strategy
Unilever's acquisition of Grüns signals a strategic shift towards high-growth health and wellbeing segments, leveraging Grüns' digital-native model and rapid market penetration in the US greens supplement category.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 10 April 2026
Unilever has acquired US-based greens supplement brand Grüns, a move indicating a strategic reorientation towards the high-growth health and wellbeing sector. This acquisition follows Unilever's recent announcement to divest its significant food business, a transaction valued at nearly $45 billion, enabling a sharpened focus on more dynamic portfolios. The Grüns acquisition, expected to finalise later this year, sees Unilever incorporating a brand that achieved a $500 million valuation by 2025.
Grüns, established in 2023 by Chad Janis, has rapidly ascended within the US supplement market. Its success is attributed to a digitally native, culture-driven brand strategy promoting customer adherence, validated by its rapid expansion into over 6,000 brick-and-mortar locations including major retailers like Sprouts, Walmart, Target, and Sam’s Club. The brand reported an annualised revenue rate of $300 million by its 24th month of operation.
Unilever's Wellbeing CEO, Jostein Solheim, emphasised Grüns' focus on 'science-backed products' and 'consistent use,' identifying significant scaling opportunities. Grüns' product line has broadened since its inception, introducing Grüns Kids and Nütrops for cognitive support in 2024, followed by Immün for immune support and Jüced for energy in 2025. The brand currently ships 10 million gummies daily, serving over one million customers, underscoring its operational capacity and consumer reach.
This deal strengthens Unilever's existing health and wellbeing portfolio, which already includes Liquid I.V., Olly, SmartyPants Vitamins, and Nutrafol. The integration of Grüns allows Unilever to capitalise on consumer demand for convenient, palatable supplement formats, particularly within the 'greens' category.
What this means for United Kingdom
UK brand owners should observe this acquisition as a bellwether for potential strategic shifts among major FMCG players. The rapid growth and valuation of Grüns underscore the market potential for digitally native, convenient format supplements, particularly in the 'greens' and 'gummy' categories. UK manufacturers should scrutinise their own product development pipelines for innovation in taste, adherence, and digital engagement. Regulatory teams should prepare for potential increased scrutiny on 'greens' supplement claims if larger players drive market expansion. Given high ingredient costs, UK brand owners entering this space will need robust supply chain strategies and strong e-commerce capabilities to mirror Grüns' rapid market penetration and margin profiles.
Founder Chad Janis noted the acquisition's primary intent is to support growth and reach more consumers with Grüns products. This suggests a continued investment in brand expansion and product accessibility under Unilever's stewardship.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.